Former NMPA deputy director under investigation
Chen Shifei, former deputy director of China's top drug regulator, is under investigation for suspected serious violations of Party discipline and national laws, China's top anti-corruption watchdogs said on Wednesday.
The probe was announced by the Communist Party of China Central Commission for Discipline Inspection and the National Commission of Supervision online, with no additional details disclosed.
Public information shows that the 63-year-old, a native of Zhejiang province, graduated with a degree in pharmacy in 1983 from China Pharmaceutical University in Nanjing, Jiangsu province.
He had been serving in the drug regulation bureau in Zhejiang province for a long time before being promoted as deputy director of the National Medical Products Administration in 2018. He retired in 2022.
- Former NMPA deputy director under investigation
- Hong Kong's economy expected to grow 2 to 3 pct in 2025
- Search, rescue underway after boat collision in Central China
- Hong Kong reinforces fiscal consolidation in new budget
- Xi stresses new responsibilities, actions in advancing Chinese modernization
- Former deputy head of China's medical products regulator under probe
